disopyramide has been researched along with procainamide in 181 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 136 (75.14) | 18.7374 |
| 1990's | 21 (11.60) | 18.2507 |
| 2000's | 14 (7.73) | 29.6817 |
| 2010's | 10 (5.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barcelon-Yang, C; Brown, BS; Matier, WL; Reynolds, RD; Stout, DM | 1 |
| Giacomini, KM; Schaner, ME; Zhang, L | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Akazawa, M; Inui, K; Masuda, S; Okuda, M; Saito, H; Urakami, Y | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Theisen, K | 1 |
| Donaldson, RM | 1 |
| Carson, IW; Lyons, SM; Shanks, RG | 1 |
| Boschi, S; Bracchetti, D; Lamberti, C; Magnani, B; Mantovani, B; Naccarella, F | 1 |
| Ruffy, R; Zipes, DP | 1 |
| Romankiewicz, JA | 1 |
| Singh, BN | 1 |
| Shand, DG; Woosley, RL | 1 |
| Koch-Weser, J | 1 |
| Millar-Craig, MW; Raftery, EB | 1 |
| Forester, D | 1 |
| Federman, J; Vlietstra, RE | 1 |
| Chiba, S; Furukawa, Y; Kobayashi, M | 1 |
| Pennock, RS | 1 |
| Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
| Lagerström, PO; Persson, BA | 1 |
| Goldman, P; Ingelfinger, JA | 1 |
| Ankier, SI; Grant, AM; Marshall, RJ | 1 |
| Mason, JW; Winkle, RA | 1 |
| Farshidi, A; Greenspan, AM; Horowitz, LN; Josephson, ME; Michelson, EL; Spielman, SR | 1 |
| Martin, RP; McMorrow, M; Meltzer, RS; Robert, EW | 1 |
| Arnsdorf, MF; Mehlman, DJ | 1 |
| Binetti, G; Branzi, A; Magelli, C; Magnani, B; Malini, PL; Specchia, S; Zannoli, R | 1 |
| Barrillon, A; Grand, A | 1 |
| Kidner, PH | 1 |
| Amat-y-Leon, F; Denes, P; Latif, P; Rosen, KM; Simpson, RJ; Wu, D; Wyndham, CR | 1 |
| Arita, M; Kiyosue, T; Sato, T; Wu, B | 1 |
| Fujiki, A; Sasayama, S; Tani, M; Yoshida, S | 1 |
| Fomina, IG; Iankin, VV | 1 |
| Boudoulas, H; Coyle, JD; Lewis, RP; Lima, JL; Mackichan, JJ | 1 |
| Kurbanov, RD | 1 |
| Ito, M; Nagashima, M; Noshiro, H; Odakura, H; Onodera, S; Shinoda, S; Suzuki, H; Yasuda, S | 1 |
| Grosu, AA; Shevchenko, NM | 1 |
| Fukuzaki, H; Takarada, A; Yokota, Y | 1 |
| Fisher, JD; Kim, SG; Matos, JA; Seiden, SW; Waspe, LE | 1 |
| Roden, DM | 1 |
| Podrid, PJ | 3 |
| Keefe, DL; Miura, D; Somberg, JC | 1 |
| Greenspan, AM; Horowitz, LN; Spielman, SR | 1 |
| Au, PK; Bhandari, AK; Bream, R; Rahimtoola, SH; Schreck, D; Siddiqi, R | 1 |
| Gorshkov, VA; Mamaev, VI; Shpektor, AV | 1 |
| Gorshkov, VA; Kurakina, TI; Mamaev, VI; Sherashov, VS; Shpektor, AV | 1 |
| Kawakubo, K; Murakawa, Y; Nozaki, A; Sugimoto, T; Toda, I | 1 |
| Fujimoto, T; Fukuzaki, H; Inoue, T; Itoh, S; Kaneda, S; Miwa, S; Ogawa, H; Ohnishi, Y; Yoneda, N | 1 |
| Somberg, J | 1 |
| Roden, DM; Siddoway, LA; Woosley, RL | 1 |
| Roy, D | 1 |
| Ito, H; Kurachi, Y; Nakajima, T; Sugimoto, T; Takikawa, R | 1 |
| Echt, DS; Roden, DM; Woosley, RL | 1 |
| Andersson, KE; Wettrell, G | 1 |
| Morganroth, J; Nestico, PF | 3 |
| Huang, SK; Marcus, FI | 1 |
| Proelss, HF; Townsend, TB | 1 |
| Light, RT; Onrot, J; Robertson, D; Robertson, RM; Tantengco, MV | 1 |
| Kates, RE | 2 |
| Kobayashi, A; Watanabe, H; Yamazaki, N | 1 |
| Garan, H; McElroy, M; McGovern, B; Newell, JB; Ruskin, JN; Schoenfeld, MH; Whitford, EG | 1 |
| Bauma, W; Bauman, JL; Beckman, KJ; Berry, NS; Gallastegui, JL; Hariman, RJ | 1 |
| Heger, JJ; Miles, WM; Minardo, JD; Prystowsky, EN; Zipes, DP | 1 |
| Longo, A; Ribeiro, C | 1 |
| Duff, HJ; Mitchell, LB; Wyse, DG | 1 |
| Ikeda, K; Kamakura, S; Matsuhisa, M; Ohe, T; Shimomura, K; Yamamoto, K | 1 |
| Bardy, GH; Fahrenbruch, CE; Graham, EL; Greene, HL; Poole, JE; Pulaski, WP; Werner, JA | 1 |
| Akioka, K; Horiguchi, T; Ikuno, Y; Inoue, E; Oku, H; Takeda, T; Takeuchi, K; Teragaki, M; Toda, I; Yasuda, M | 1 |
| Ishinaga, T; Komatsu, C; Tateishi, O; Tokuhisa, Y; Yoshimura, S | 1 |
| Gardner, MJ; Josephson, ME; McCarthy, DM | 1 |
| Barland, P; Epstein, A | 1 |
| Collignon, P; Legrand, V | 1 |
| Atarashi, H; Hayakawa, H | 1 |
| Hiejima, K; Hirao, K; Kubo, I; Moroi, Y; Satake, S; Suzuki, F | 1 |
| Chiba, S; Kobayashi, M; Shimotori, M | 2 |
| Hashimoto, K; Imai, S; Shibuya, T | 1 |
| Hashimoto, S; Kanazawa, T; Miura, M; Ono, Y | 1 |
| Hauswirth, O; Singh, BN | 1 |
| Lomanto, B; Rossi, A; Sanna, GP | 1 |
| Carlier, J; Lisin, N | 1 |
| De Thomatis, M | 1 |
| Opie, LH | 1 |
| Reid, PR; Vlay, SC | 1 |
| Elkayam, U; Frishman, W; Rotmensch, HH | 1 |
| Hillis, WS; Whiting, B | 1 |
| Kuch, J | 1 |
| Prystowsky, EN | 1 |
| Somberg, JC | 1 |
| Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
| Lalka, D; McNamara, PJ; Pieper, JA; Slaughter, RL; Wyman, MG | 1 |
| Halawa, B; Mazurek, W | 1 |
| Bracchetti, D; Cantelli, I; Del Corso, P; Lentini, G; Naccarella, F; Palmieri, M | 1 |
| Lasky, FD; Wesley, JF | 1 |
| Howanitz, JH; Howanitz, PJ | 1 |
| Roden, DM; Woosley, RL | 1 |
| Kerr, CR; Levick, CE; Mizgala, HF | 1 |
| Mirro, MJ | 1 |
| Rosen, MR; Wit, AL | 1 |
| Block, PJ; Winkle, RA | 1 |
| DePace, NL; Morganroth, J; Nestico, PF | 1 |
| Fuster, V; Goldman, ME; Kupersmith, J; Schweitzer, P; Squire, A; Stern, EH | 1 |
| Berbari, EJ; Dehning, MM; Friday, KJ; Harrison, LA; Jackman, WM; Lazzara, R; Olson, EG; Reynolds, DW; Schechter, E; Scherlag, BJ | 1 |
| Gebhardt, VA; Goddard, MD; Gryfe-Becker, B; Nichol, PM; Prato, FS; Rechnitzer, PA; Wisenberg, G; Zawadowski, AG | 1 |
| Bricaud, H; Lévy, RH; Lévy, S | 1 |
| Cho, YW; Kuemmerle, HP; Singh, BN | 1 |
| Flouvat, B | 1 |
| Hirosawa, K; Kasanuki, H; Ohnishi, S | 1 |
| Hata, Y; Ichimaru, Y; Kodama, Y; Okamoto, K; Otsuka, K; Ueno, T; Yanaga, T | 1 |
| Hiejima, K; Satake, S; Suzuki, F; Takahashi, M | 1 |
| Buxton, AE; Josephson, ME; Sadowski, LM; Waxman, HL | 1 |
| Bauernfeind, RA; Coelho, A; Gallastegui, J; Petropoulos, AT; Rosen, KM; Swiryn, S | 1 |
| Chiariello, M; Condorelli, M; Ferro, G; Tari, MG; Ungaro, B; Vigorito, C | 1 |
| Bauernfeind, RA; Duffy, CE; Palileo, E; Rosen, KM; Strasberg, B; Swiryn, S | 1 |
| Arensberg, D; Felner, JM; Stanford, JL | 1 |
| Carlier, J | 1 |
| Irvin, WS; Wanner, WR | 1 |
| Dreifus, LS; Morganroth, J | 1 |
| Moses, HW; Yu, PN | 1 |
| Witkowska, M | 1 |
| McAnulty, JH; Metcalfe, J; Ueland, FR; Ueland, K | 1 |
| Garfein, OB | 1 |
| Finlay, M | 1 |
| Drake, CE | 1 |
| Bauernfeind, RA; Palileo, E; Rosen, KM; Scagliotti, D; Strasberg, B; Swiryn, SP | 1 |
| Coelho, A; Rosen, KM; Strasberg, B; Welch, WJ | 1 |
| Bauernfeind, RA; Iverson, N; Levy, PS; Palileo, E; Rosen, KM; Strasberg, B; Swiryn, S | 1 |
| Gulamhusein, S; Klein, GJ; Ko, PT; Kostuk, WJ | 1 |
| Comess, KA; Fenster, PE; Hanson, CD | 1 |
| Bailey, JC; Manalan, AS; Mirro, MJ; Watanabe, AM | 1 |
| Chen, SH; Kabra, PM; Marton, LJ | 1 |
| Affrime, MB; Lowenthal, DT | 1 |
| McEniry, DW; Skorton, DJ | 1 |
| Chiavarelli, V; Milazzotto, F; Vajola, SF | 1 |
| Bracchetti, D; Lombardi, G; Mantovani, B; Naccarella, F; Palmieri, M | 1 |
| Herling, IM; Horowitz, LN; Josephson, ME | 1 |
| Bailey, JC; Mirro, MJ; Watanabe, AM | 1 |
| Abbott, JA; Cheitlin, MD; Desai, J; Holford, N; Peters, RW; Remedios, P; Scheinman, MM | 1 |
| Bigger, JT; Giardina, EG; Leahey, EB; Reiffel, JA | 1 |
| Harken, AH; Horowitz, LN; Josephson, ME; Vetter, VL | 1 |
| Grey, E; Silverman, DI | 1 |
| Asayama, J; Inoue, D; Inoue, M; Ishibashi, K; Nakagawa, M; Sakai, R; Shirayama, T | 1 |
| Fujiki, A; Inoue, H; Tani, M; Yoshida, S | 2 |
| Fiksinski, E; Martin, D; Venditti, F | 1 |
| Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
| Aizawa, Y; Mitamura, H; Miyazaki, T; Miyoshi, S; Ogawa, S; Soejima, K | 1 |
| Aizawa, Y; Ebe, K; Shibata, A | 1 |
| Aizawa, Y; Chinushi, M; Naitoh, N; Shibata, A | 1 |
| Doi, T; Inoue, T; Ohga, N; Yokoyama, M; Yoshida, A | 1 |
| Aizawa, Y; Tanabe, Y; Yamaura, M | 1 |
| Ruskin, JN | 1 |
| Izumi, T; Kitano, Y; Moriguchi, M; Niwano, S | 1 |
| Iost, N; Papp, JG; Varró, A; Virág, L | 1 |
| Benest, AV; Hancox, JC; Masters, JD; Milnes, JT; Ridley, JM; Witchel, HJ | 1 |
| Endou, H; Enomoto, A; Hasannejad, H; Huang, XL; Jung, SH; Narikawa, S; Niwa, T; Onozato, ML; Takeda, M; Taki, K; Tojo, A | 1 |
39 review(s) available for disopyramide and procainamide
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Anti-arrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Anesthetics; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Humans; Intraoperative Complications; Lidocaine; Mexiletine; Phenytoin; Procainamide; Succinylcholine | 1979 |
Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
Topics: Action Potentials; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Disopyramide; Heart; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine; Sympatholytics; Time Factors | 1978 |
Pharmacokinetics of antiarrhythmic drugs.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Glycine; Half-Life; Injections, Intravenous; Kinetics; Lidocaine; Procainamide; Quinidine | 1978 |
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
[Incompatibility and interference of the major cardiologic drugs. Their undesirable effects].
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antihypertensive Agents; Bradycardia; Cardiac Glycosides; Digitalis Glycosides; Disopyramide; Drug Interactions; Drug Synergism; Humans; Hypertension; Hypokalemia; Isoproterenol; Lidocaine; Monoamine Oxidase Inhibitors; Ouabain; Phenytoin; Prenylamine; Procainamide; Quinidine | 1976 |
[Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Humans; Moricizine; Phenothiazines; Procainamide; Propranolol | 1991 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
The treatment of ventricular rhythm disturbances.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Electric Countershock; Electric Stimulation; Electrocardiography; Exercise Test; Flecainide; Heart Ventricles; Humans; Lidocaine; Phenytoin; Piperidines; Procainamide; Quinidine; Risk; Tachycardia; Tocainide; United States; Ventricular Fibrillation; Verapamil | 1986 |
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Heart Conduction System; Heart Ventricles; Humans; Monitoring, Physiologic; Procainamide; Quinidine; Tachycardia | 1986 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Digitalis; Disopyramide; Drug Interactions; Encainide; Flecainide; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Lidocaine; Liver; Piperidines; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Quinidine; Regional Blood Flow; Tocainide | 1986 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
Procainamide and disopyramide.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Procainamide | 1987 |
[Treatment of extrasystole (ventricular and atrial extrasystoles)].
Topics: Adrenergic beta-Antagonists; Ajmaline; Aniline Compounds; Benzyl Compounds; Cardiac Complexes, Premature; Disopyramide; Hemodynamics; Humans; Imidazoles; Lidocaine; Phenytoin; Procainamide; Propanolamines; Propranolol; Quinidine | 1974 |
Comparative mechanisms of action of antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Benzyl Compounds; Bretylium Compounds; Calcium; Carbamazepine; Chemical Phenomena; Chemistry; Diethylamines; Disopyramide; Heart; Humans; Imidazoles; Iodobenzoates; Lidocaine; Membrane Potentials; Phenyl Ethers; Phenytoin; Procainamide; Propylamines; Quinidine; Verapamil | 1974 |
Antiarrhythmic drug therapy during pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Digitalis Glycosides; Disopyramide; Female; Fetus; Humans; Infant, Newborn; Lidocaine; Maternal-Fetal Exchange; Phenytoin; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide; Quinidine; Tachycardia; Verapamil | 1983 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Disopyramide; Encainide; Female; Humans; Lidocaine; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
Antiarrhythmic drug monitoring.
Topics: Acecainide; Anti-Arrhythmia Agents; Disopyramide; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1981 |
Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide.
Topics: Acecainide; Animals; Anti-Arrhythmia Agents; Disopyramide; Drug Interactions; Electrocardiography; Electrophysiology; Humans; Kinetics; Procainamide; Quinidine | 1983 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Heart Ventricles; Humans; Lidocaine; Procainamide; Propranolol; Quinidine; Tocainide | 1984 |
New insights into the drug treatment of ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Disopyramide; Humans; Kinetics; Lidocaine; Procainamide; Propranolol; Quinidine; Tocainide | 1984 |
Metabolites of cardiac antiarrhythmic drugs: their clinical role.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Disopyramide; Encainide; Humans; Lidocaine; Piperidines; Procainamide; Quinidine | 1984 |
Antiarrhythmic agents and their use in therapy.
Topics: Acebutolol; Animals; Anti-Arrhythmia Agents; Digitalis Glycosides; Disopyramide; Humans; Lidocaine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1980 |
Antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Bretylium Tosylate; Disopyramide; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1980 |
[Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
Topics: Arrhythmias, Cardiac; Biological Availability; Disopyramide; Half-Life; Humans; Intestinal Absorption; Kinetics; Procainamide; Pyridines; Quinidine | 1981 |
Special considerations in the use of cardiovascular drugs.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Cardiac Glycosides; Cardiovascular Agents; Disopyramide; Diuretics; Female; Fetus; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide; Propranolol; Quinidine | 1981 |
Pharmacology of commonly used antiarrhythmic drugs and comments on the use of therapeutic drug monitoring.
Topics: Anti-Arrhythmia Agents; Disopyramide; Humans; Kinetics; Lidocaine; Procainamide; Propranolol; Quinidine | 1982 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Electrocardiography; Electrophysiology; Heart Conduction System; Humans; Imidazoles; Mexiletine; Procainamide; Tachycardia, Ventricular | 1998 |
14 trial(s) available for disopyramide and procainamide
| Article | Year |
|---|---|
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
A double-blind trial of disopyramide, procaineamide and digoxin in paroxysmal suptraventricular tachycardia.
Topics: Adult; Aged; Clinical Trials as Topic; Digoxin; Disopyramide; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Procainamide; Pyridines; Tachycardia, Paroxysmal | 1979 |
[Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
Topics: Adult; Aged; Aged, 80 and over; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Pre-Excitation Syndromes; Procainamide; Propranolol; Quinidine; Time Factors; Verapamil | 1992 |
Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
Topics: Aged; Ambulatory Care; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Procainamide; Quinidine; Tachycardia; Time Factors; Ventricular Fibrillation | 1985 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Heart Conduction System; Heart Ventricles; Humans; Monitoring, Physiologic; Procainamide; Quinidine; Tachycardia | 1986 |
[Comparative effectiveness of neogilurytmal, novocainamide, etmozin, disopyramide and ethacizine in ventricular arrhythmias].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Prajmaline; Procainamide; Tachycardia, Paroxysmal | 1987 |
[Comparative effectiveness of neogilurytmal, novocainamide, ethmozin, disopyramide and ethacizin in supraventricular extrasystole].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Prajmaline; Procainamide | 1986 |
Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Disopyramide; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Procainamide; Quinidine; Radionuclide Imaging; Stroke Volume | 1984 |
A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Disopyramide; Female; Humans; Male; Muscle Contraction; Myotonic Dystrophy; Procainamide; Pyridines; Random Allocation | 1982 |
Effect of antidysrhythmic drugs on the heart rate and blood pressure response to treadmill exercise.
Topics: Adult; Anti-Arrhythmia Agents; Blood Pressure; Disopyramide; Exercise Test; Female; Heart Rate; Humans; Male; Procainamide | 1982 |
Clinical characteristics and EPS-guided therapy in 142 cases of sustained ventricular tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Catheter Ablation; Combined Modality Therapy; Disopyramide; Electrophysiology; Female; Follow-Up Studies; Humans; Male; Middle Aged; Procainamide; Tachycardia, Ventricular; Treatment Outcome | 1996 |
Effects of class IA antiarrhythmic drugs on the reentrant circuit in common human atrial flutter.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Electrophysiology; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Procainamide | 1995 |
Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electrophysiology; Female; Heart Conduction System; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Procainamide; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 1996 |
131 other study(ies) available for disopyramide and procainamide
| Article | Year |
|---|---|
Synthesis and antiarrhythmic and parasympatholytic properties of substituted phenols. 2. Amides.
Topics: Amides; Animals; Anti-Arrhythmia Agents; Chemical Phenomena; Chemistry; Dogs; Electric Stimulation; Guinea Pigs; Heart Rate; Ileum; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Methacholine Chloride; Methacholine Compounds; Muscle Contraction; Parasympatholytics; Structure-Activity Relationship | 1984 |
Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
Topics: Carrier Proteins; Corticosterone; HeLa Cells; Humans; Membrane Proteins; Midazolam; Organic Cation Transporter 1; Permeability; Recombinant Proteins; Structure-Activity Relationship; Tetraethylammonium Compounds; Transfection | 1998 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.
Topics: Animals; Cell Line; Dogs; Kidney; Kidney Tubules; Kinetics; Membranes; Nephrons; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Rats; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substrate Specificity; Tetraethylammonium; Transfection | 2001 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digoxin; Disopyramide; Electric Countershock; Humans; Phenytoin; Procainamide; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1979 |
[Computerized analysis of the clinical effectiveness of intravenous/disopyramide and procainamide in patients with stabilized and complicated ventricular extrasystole].
Topics: Cardiac Complexes, Premature; Computers; Disopyramide; Drug Evaluation; Electrocardiography; Hemodynamics; Humans; Procainamide; Pyridines | 1979 |
Preventing ventricular arrhythmias in ischemic heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Lidocaine; Nitroglycerin; Procainamide; Quinidine | 1979 |
Pharmacology update: oral antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Disopyramide; Humans; Procainamide; Quinidine | 1979 |
Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Atrial Fibrillation; Disopyramide; Humans; Injections, Intravenous; Lidocaine; Procainamide; Pyridines; Quinidine; Tachycardia; Ventricular Fibrillation; Wolff-Parkinson-White Syndrome | 1979 |
Series on pharmacology in practice. 2. Antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Bretylium Compounds; Disopyramide; Humans; Lidocaine; Metoprolol; Procainamide; Propranolol; Quinidine; Verapamil | 1979 |
Effects of disopyramide on SA nodal pacemaker activity and contractility in the isolated blood-perfused atrium of the dog.
Topics: Animals; Blood Pressure; Calcium; Disopyramide; Dogs; Heart Rate; In Vitro Techniques; Myocardial Contraction; Norepinephrine; Procainamide; Pyridines; Sinoatrial Node; Verapamil | 1979 |
How useful are serum levels of cardiac drugs?
Topics: Anti-Arrhythmia Agents; Digitalis Glycosides; Disopyramide; Heart Diseases; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1978 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Chromatography, High Pressure Liquid; Disopyramide; Lidocaine; Procainamide; Quinidine | 1978 |
Therapy with antiarrhythmic drugs.
Topics: Acetylation; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Heart Failure; Humans; Indocyanine Green; Infusions, Parenteral; Lidocaine; Liver; Lupus Erythematosus, Systemic; Myocardial Infarction; Procainamide | 1978 |
Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle.
Topics: Action Potentials; Animals; Dealkylation; Disopyramide; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Lidocaine; Myocardial Contraction; Nervous System; Neural Conduction; Procainamide; Propranolol; Pyridines; Quinidine; Rats | 1978 |
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Evaluation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Monitoring, Physiologic; Phenytoin; Procainamide; Propranolol; Quinidine; Recurrence; Tachycardia | 1978 |
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Evaluation; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Phenytoin; Procainamide; Quinidine; Recurrence; Tachycardia | 1978 |
Treatment of cardiac arrhythmias. Part II--The drugs.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Electric Countershock; Humans; Lidocaine; Pacemaker, Artificial; Phenytoin; Procainamide; Propranolol; Quinidine | 1978 |
Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Topics: Administration, Oral; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart Conduction System; Humans; Middle Aged; Procainamide; Propranolol; Pyridines; Quinidine; Tachycardia | 1978 |
Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Heart Conduction System; In Vitro Techniques; Lidocaine; Membrane Potentials; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Sheep; Time Factors | 1978 |
[Hemodynamic effects of disopyramide and procainamide in open-chest animals].
Topics: Animals; Bradycardia; Disopyramide; Heart Rate; Hemodynamics; Procainamide; Pyridines; Sinoatrial Node; Swine; Thoracic Surgery; Thorax | 1978 |
Prevention of ventricular arrhythmias after myocardial infarction.
Topics: Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Procainamide; Propranolol; Quinidine; Ventricular Fibrillation | 1977 |
Electrophysiological studies with multiple drugs in patients with atrioventricular re-entrant tachycardias utilizing an extranodal pathway.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Aprindine; Atrioventricular Node; Bundle of His; Cardiac Pacing, Artificial; Child; Digoxin; Disopyramide; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Ouabain; Procainamide; Propranolol; Tachycardia, Paroxysmal | 1977 |
Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
Topics: 2,4-Dinitrophenol; Action Potentials; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Dinitrophenols; Disopyramide; Flecainide; Glyburide; Guinea Pigs; Heart Ventricles; Imidazoles; Lidocaine; Mexiletine; Myocardium; Piperidines; Potassium; Procainamide; Pyridines | 1992 |
[Evaluation of drug efficacy for preventing paroxysmal atrial fibrillation].
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Disopyramide; Drug Evaluation; Electrocardiography, Ambulatory; Electrophysiology; Female; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide | 1992 |
Differential effect of class 1A antiarrhythmic drugs on the relationship between electrical and electromechanical systole.
Topics: Disopyramide; Electrocardiography; Humans; Procainamide; Quinidine; Systole | 1991 |
Effect of class Ia antiarrhythmic agents on fasciculoventricular fibers.
Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Electrophysiology; Female; Heart Conduction System; Humans; Male; Pre-Excitation, Mahaim-Type; Procainamide | 1990 |
[The potentials for curing atrial flutter by the combined use of transesophageal electrical stimulation and anti-arrhythmia preparations].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Chronic Disease; Combined Modality Therapy; Disopyramide; Electrocardiography; Esophagus; Female; Humans; Male; Middle Aged; Procainamide | 1990 |
Analysis of ventricular arrhythmias in patients with dilated cardiomyopathy--relationship between the effects of antiarrhythmic agents and severity of myocardial lesions.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Disopyramide; Electrocardiography, Ambulatory; Female; Fibrosis; Follow-Up Studies; Hemodynamics; Humans; Male; Mexiletine; Middle Aged; Myocardium; Procainamide | 1990 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action Preparations; Disopyramide; Heart Arrest; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Procainamide; Resuscitation; Tocainide | 1985 |
Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Disopyramide; Female; Heart Diseases; Humans; Male; Middle Aged; Procainamide; Prospective Studies; Quinidine; Tachycardia | 1987 |
Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Disopyramide; Dogs; Heart; Lidocaine; Mexiletine; Procainamide; Ventricular Fibrillation | 1989 |
The effects of class IA antiarrhythmic drug on the common type of atrial flutter in combination with pacing therapy.
Topics: Adult; Aged; Atrial Flutter; Cardiac Pacing, Artificial; Combined Modality Therapy; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide | 1989 |
Antiarrhythmic drug therapy (Part 1). Benefits and hazards.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Electrocardiography; Electrophysiology; Heart; Humans; Lidocaine; Procainamide; Quinidine | 1985 |
Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms.
Topics: Animals; Biomechanical Phenomena; Disopyramide; Guanosine Triphosphate; Guinea Pigs; Heart; In Vitro Techniques; Myocardium; Parasympatholytics; Potassium Channels; Procainamide; Quinidine; Receptors, Muscarinic; Receptors, Purinergic | 1989 |
Simultaneous liquid-chromatographic determination of five antiarrhythmic drugs and their major active metabolites in serum.
Topics: Anti-Arrhythmia Agents; Buffers; Chromatography, High Pressure Liquid; Disopyramide; Ethylamines; Heart Diseases; Humans; Hydrogen-Ion Concentration; Lidocaine; Procainamide; Quinidine; Temperature; Tocainide | 1986 |
Orthostatic hypotension: clinical spectrum and approach to treatment.
Topics: Adult; Aged; Amiodarone; Disopyramide; Female; Flecainide; Humans; Hypotension, Orthostatic; Lidocaine; Male; Middle Aged; Piperidines; Procainamide; Quinidine; Sympathomimetics; Tocainide | 1986 |
Metabolites of antiarrhythmic drugs: are they clinically important?
Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Procainamide; Quinidine | 1986 |
Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
Topics: Acyl Coenzyme A; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Disopyramide; Dogs; Fatty Acids, Nonesterified; Female; Male; Myocardium; Procainamide | 1988 |
Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Tachycardia; Time Factors | 1988 |
Analysis of antiarrhythmic drug concentrations determined during electrophysiologic drug testing in patients with inducible tachycardias.
Topics: Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrophysiology; Humans; Procainamide; Quinidine; Tachycardia; Tachycardia, Supraventricular | 1988 |
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Disopyramide; Diuretics; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Quinidine; Recurrence; Retrospective Studies; Stroke Volume; Ventricular Fibrillation | 1988 |
Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
Topics: Adult; Aged; Disopyramide; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Ventricular Fibrillation | 1987 |
[Electrophysiological studies in 2 patients with chronic persistent atrial tachycardia].
Topics: Adult; Disopyramide; Electrocardiography; Electrophysiology; Female; Humans; Lidocaine; Middle Aged; Procainamide; Tachycardia | 1987 |
Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Topics: Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Humans; Male; Mexiletine; Middle Aged; Monitoring, Physiologic; Nausea; Procainamide; Propylamines; Quinidine; Recurrence; Tachycardia; Tremor; Ventricular Fibrillation | 1986 |
[Three cases of torsades de pointes due to anti-arrhythmic agents].
Topics: Aged; Aged, 80 and over; Disopyramide; Electrocardiography; Female; Humans; Middle Aged; Procainamide; Quinidine; Tachycardia | 1986 |
Effects of four antiarrhythmic drugs on the induction and termination of paroxysmal supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Female; Humans; Male; Middle Aged; Procainamide; Propranolol; Tachycardia, Supraventricular; Verapamil | 1986 |
Effect of myocardial ischemia and type I antiarrhythmic drug therapy on exercise QT intervals.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test; Heart Conduction System; Humans; Long QT Syndrome; Male; Middle Aged; Procainamide; Quinidine | 1985 |
The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus.
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Autoantibodies; Child; Disopyramide; Female; Fluorescent Antibody Technique; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Middle Aged; Penicillamine; Phenytoin; Procainamide | 1985 |
Aggravation of ventricular arrhythmia. A drug-induced complication.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
Haemodynamic effects of class I antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Disopyramide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1985 |
[Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Bundle of His; Disopyramide; Electrocardiography; Electrodes; Female; Humans; Male; Middle Aged; Procainamide; Tachycardia, Paroxysmal; Verapamil; Wolff-Parkinson-White Syndrome | 1985 |
A comparative study of sinoatrial conduction time with therapeutic doses of antiarrhythmic agents in isolated cross-perfused canine atria.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Disopyramide; Dogs; Electric Stimulation; Heart Atria; Heart Rate; In Vitro Techniques; Perfusion; Procainamide; Propranolol; Sinoatrial Node | 1985 |
Cardiovascular and respiratory effects of antiarrhythmic drugs on conscious beagles.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Disopyramide; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Lidocaine; Male; Phenytoin; Procainamide; Respiration; Verapamil | 1985 |
[Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
Topics: Administration, Oral; Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Diethylamines; Disopyramide; Dogs; Heart Ventricles; Humans; Indans; Injections; Injections, Intravenous; Myocardial Infarction; Practolol; Procainamide; Propranolol; Quinidine; Tachycardia | 1974 |
[Electrophysiological principles of the action of antiarrhythmia agents].
Topics: Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrophysiology; Heart; Humans; Lidocaine; Procainamide; Quinidine | 1974 |
[Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
Topics: Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Aorta; Blood Pressure; Cardiac Output; Diethylamines; Disopyramide; Dogs; Heart Rate; Heart Ventricles; Hemodynamics; Indans; Indenes; Injections, Intravenous; Phenytoin; Procainamide; Pulmonary Artery; Quinidine; Respiration; Vascular Resistance | 1974 |
[Medical treatment of disturbances of the heart rhythm].
Topics: Ajmaline; Amiodarone; Arrhythmias, Cardiac; Digoxin; Disopyramide; Humans; Procainamide; Propranolol | 1973 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Heart Conduction System; Hemodynamics; Humans; Lidocaine; Mexiletine; Procainamide; Quinidine; Verapamil | 1980 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Echocardiography; Electric Stimulation; Humans; Ischemia; Lidocaine; Myocardial Infarction; Nitrates; Pacemaker, Artificial; Phenytoin; Procainamide; Radionuclide Imaging; Risk | 1982 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
[Pharmacological treatment of arrhythmia].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Disopyramide; Drug Evaluation; Heart Conduction System; Humans; Procainamide; Quinidine | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Factors influencing serum protein binding of lidocaine in humans.
Topics: Acecainide; Blood Proteins; Bupivacaine; Disopyramide; Humans; Lidocaine; Orosomucoid; Procainamide; Propranolol; Protein Binding; Quinidine; Serum Albumin | 1981 |
[Effect of various anti-arrhythmia drugs on serum digoxin level].
Topics: Aged; Anti-Arrhythmia Agents; Biological Availability; Cardiac Complexes, Premature; Digoxin; Disopyramide; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Phenytoin; Procainamide; Quinidine | 1981 |
[Dynamic electrocardiography evaluation of the effectiveness of prajmalium bitartrate, disopyramide and procainamide in patients with stabilized ventricular extrasystole].
Topics: Adolescent; Adult; Ajmaline; Cardiac Complexes, Premature; Disopyramide; Electrocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Monitoring, Physiologic; Prajmaline; Procainamide; Pyridines | 1981 |
High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts.
Topics: Acecainide; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Disopyramide; Humans; Procainamide; Propranolol; Pyridines; Quinidine; Spectrophotometry, Ultraviolet | 1981 |
Failure to pace following high dose antiarrhythmic therapy--reversal with isoproterenol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electrocardiography; Humans; Isoproterenol; Pacemaker, Artificial; Phenytoin; Procainamide; Tachycardia | 1984 |
Effects of quinidine, procainamide and disopyramide on automaticity and cyclic AMP content of guinea-pig atria.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Function; Cyclic AMP; Depression, Chemical; Disopyramide; Guinea Pigs; Heart; Heart Rate; Male; Procainamide; Pyridines; Quinidine | 1981 |
Long-term antiarrhythmic therapy. Problem of low drug levels and patient noncompliance.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Female; Heart Diseases; Humans; Male; Middle Aged; Patient Compliance; Procainamide; Quinidine; Self Administration; Time Factors | 1984 |
Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation.
Topics: Adult; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Disopyramide; Ebstein Anomaly; Electric Stimulation Therapy; Electrocardiography; Electrophysiology; Endocardium; Female; Heart Block; Heart Conduction System; Humans; Procainamide; Propranolol; Wolff-Parkinson-White Syndrome | 1983 |
Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electric Stimulation; Heart Rate; In Vitro Techniques; Myocardial Contraction; Procainamide; Propranolol; Quinidine; Sinoatrial Node | 1984 |
[Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Disopyramide; Humans; Kinetics; Lidocaine; Perfusion; Phenytoin; Procainamide; Propranolol; Quinidine | 1980 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Propranolol; Tocainide | 1981 |
[Determination of plasma concentrations of anti-arrhythmia agents].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biological Availability; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine | 1981 |
Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Procainamide; Recurrence; Tachycardia; Verapamil | 1983 |
The usefulness of Holter monitoring in the evaluation of antiarrhythmic drug efficacy for tachycardia.
Topics: Adult; Aged; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Diltiazem; Disopyramide; Female; Heart Defects, Congenital; Heart Valve Diseases; Humans; Male; Mexiletine; Middle Aged; Monitoring, Physiologic; Myocardial Infarction; Procainamide; Tachycardia; Tachycardia, Paroxysmal | 1983 |
Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Disopyramide; Electric Stimulation; Humans; Procainamide; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1983 |
The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Phenytoin; Procainamide; Quinidine; Tachycardia | 1983 |
Concordance and discordance of drug responses in atrioventricular reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Child; Disopyramide; Drug Evaluation; Drug Therapy, Combination; Electrophysiology; Female; Humans; Male; Middle Aged; Ouabain; Procainamide; Propranolol; Quinidine; Tachycardia, Paroxysmal | 1983 |
Intropic effects of several antiarrhythmic drugs.
Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Bunaftine; Coronary Disease; Disopyramide; Heart Rate; Hemodynamics; Humans; Lidocaine; Mexiletine; Middle Aged; Myocardial Contraction; Phenytoin; Procainamide | 1983 |
Inducible sustained ventricular tachycardia refractory to individual class I drugs: effect of adding a second class I drug.
Topics: Aged; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electric Stimulation; Electrophysiology; Female; Humans; Male; Middle Aged; Procainamide; Quinidine; Tachycardia, Paroxysmal | 1983 |
Antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Heart Conduction System; Humans; Lidocaine; Phenytoin; Procainamide; Quinidine | 1980 |
Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics.
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Dogs; Electrocardiography; Hemodynamics; Injections, Intravenous; Mexiletine; Myocardial Contraction; Phenytoin; Procainamide; Propylamines | 1980 |
Disopyramide and antinuclear antibodies.
Topics: Adult; Aged; Antibodies, Antinuclear; Disopyramide; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Procainamide; Pyridines | 1981 |
Cardiac drug overdose.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Cardiovascular Agents; Cardiovascular Diseases; Digoxin; Disopyramide; Humans; Hypotension; Lidocaine; Liver; Phenytoin; Procainamide; Propranolol; Quinidine; Vasodilator Agents | 1982 |
Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
Topics: Administration, Oral; Adolescent; Adult; Aprindine; Atrial Fibrillation; Cardiac Pacing, Artificial; Disopyramide; Electrophysiology; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia, Paroxysmal; Time Factors; Wolff-Parkinson-White Syndrome | 1982 |
Sustained macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procainamide; Quinidine; Recurrence; Tachycardia | 1982 |
Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Electrophysiology; Female; Heart Failure; Humans; Male; Middle Aged; Procainamide; Quinidine; Regression Analysis; Syncope; Tachycardia | 1982 |
Torsades de pointes, a common arrhythmia, induced by medication.
Topics: Aged; Anti-Arrhythmia Agents; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Aged; Phenothiazines; Procainamide; Quinidine; Syncope; Ventricular Fibrillation | 1982 |
Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade.
Topics: Animals; Atropine; Disopyramide; Female; Guinea Pigs; Heart Atria; Male; Myocardium; Parasympatholytics; Physostigmine; Procainamide; Pyridines; Quinidine; Receptors, Muscarinic; Time Factors | 1980 |
Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
Topics: Anti-Arrhythmia Agents; Chromatography, Liquid; Disopyramide; Humans; Lidocaine; Procainamide; Propranolol; Quinidine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1981 |
Cardiovascular drugs for the geriatric patient.
Topics: Aged; Aging; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular Physiological Phenomena; Digoxin; Disopyramide; Humans; Intestinal Absorption; Kidney; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1981 |
Adverse reactions to cardiovascular drugs (Part II--Antiarrhythmic agents).
Topics: Anti-Arrhythmia Agents; Disopyramide; Lidocaine; Procainamide; Quinidine | 1981 |
[Pharmacological therapy and prevention of recurrent ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bunaftine; Disopyramide; Humans; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia | 1981 |
[Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
Topics: Administration, Oral; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrophysiology; Heart Ventricles; Humans; Injections, Intravenous; Procainamide; Pyridines | 1980 |
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart Aneurysm; Heart Ventricles; Humans; Male; Middle Aged; Phenytoin; Postoperative Complications; Procainamide; Propranolol; Recurrence; Tachycardia | 1980 |
Electrophysiological effects of disopyramide and quinidine on guinea pig atria and canine cardiac purkinje fibers. Dependence on underlying cholinergic tone.
Topics: Action Potentials; Animals; Atropine; Disopyramide; Dogs; Electrophysiology; Female; Guinea Pigs; Heart Atria; Heart Conduction System; Heart Rate; Male; Parasympatholytics; Physostigmine; Procainamide; Purkinje Fibers; Pyridines; Quinidine | 1980 |
Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction.
Topics: Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Digoxin; Disopyramide; Heart Block; Heart Conduction System; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Procainamide; Propranolol; Quinidine; Time Factors | 1980 |
The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study.
Topics: Aged; Anorexia; Anti-Arrhythmia Agents; Digoxin; Disopyramide; Drug Interactions; Female; Humans; Male; Mexiletine; Middle Aged; Nausea; Procainamide; Prospective Studies; Quinidine; Vomiting | 1980 |
Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of fallot.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Child; Disopyramide; Electrocardiography; Electrophysiology; Endocardium; Female; Heart Ventricles; Humans; Male; Procainamide; Tachycardia; Tetralogy of Fallot; Time Factors | 1980 |
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Quinidine; Recurrence; Retrospective Studies | 1993 |
Effects of E-4031 on atrial fibrillation threshold in guinea pig atria: comparative study with class I antiarrhythmic drugs.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Disopyramide; Electric Stimulation; Female; Flecainide; Guinea Pigs; Heart Atria; Heart Conduction System; In Vitro Techniques; Lidocaine; Male; Piperidines; Procainamide; Pyridines; Refractory Period, Electrophysiological | 1994 |
Efficacy of class Ia antiarrhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics.
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Disopyramide; Electrophysiology; Female; Heart Atria; Humans; Male; Middle Aged; Procainamide; Tachycardia, Paroxysmal | 1994 |
Electrical proarrhythmia with procainamide: a new ICD-drug interaction.
Topics: Aged; Defibrillators, Implantable; Disopyramide; Humans; Male; Mexiletine; Procainamide; Tachycardia, Ventricular | 1994 |
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Humans; Lidocaine; Male; Mexiletine; Middle Aged; Procainamide; Syndrome; Tachycardia, Ventricular; Verapamil | 1996 |
Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Administration Schedule; Electrocardiography; Female; Heart; Humans; Imidazoles; Male; Mexiletine; Middle Aged; Procainamide; Tachycardia, Ventricular | 1996 |
Idiopathic ventricular fibrillation: is there a role for electrophysiologic-guided antiarrhythmic drug therapy?
Topics: Anti-Arrhythmia Agents; Disopyramide; Echocardiography; Humans; Procainamide; Quinidine; Ventricular Fibrillation | 1999 |
Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Procainamide; Wolff-Parkinson-White Syndrome | 2000 |
Comparison of the effect of class IA antiarrhythmic drugs on transmembrane potassium currents in rabbit ventricular myocytes.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Delayed Rectifier Potassium Channels; Disopyramide; Female; In Vitro Techniques; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Potassium Channels, Voltage-Gated; Procainamide; Quinidine; Rabbits | 2003 |
Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cell Line; Cell Membrane; Disopyramide; DNA-Binding Proteins; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Inhibitory Concentration 50; Long QT Syndrome; Membrane Potentials; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Voltage-Gated; Procainamide; Quinidine; Time Factors; Trans-Activators; Transcriptional Regulator ERG | 2003 |
Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
Topics: Animals; Anti-Arrhythmia Agents; Biological Transport; Cell Line; Disopyramide; Dose-Response Relationship, Drug; Histamine; Humans; Lidocaine; Mice; Organic Cation Transport Proteins; Phenytoin; Procainamide; Quinidine | 2004 |